Biotechnology/Biologics
FDA Announces Improved Policies Regarding Transparency, Public Disclosure for Advisory Committees
The improvements include stricter limits on financial conflicts of interest for committee members, ...
Date:
08/05/2008
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01871.html
Drug Test a Success for Amgen
The biotechnology company reported a successful trial for an experimental osteoporosis drug that reduced the risk of bone fractures in post-menopausal women.
Date:
07/26/2008
, Publication:
NY TIMES
, Author:
ANDREW POLLACK
http://www.nytimes.com/2008/07/26/business/26amgen.html?ref=health
Health Plan From Obama Spurs Debate
It is one of the most audacious promises in a campaign that has been thick with them.
Date:
07/23/2008
, Publication:
NY TIMES
, Author:
KEVIN SACK
http://www.nytimes.com/2008/07/23/us/23health.html?ref=health
FDA Rule and Companion Guidance Make Early Stage Clinical Drug Development Safe and EfficientDate:
07/19/2008
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01863.html
While the U.S. Spends Heavily on Health Care, a Study Faults the Quality
But it has fallen to last place among those countries in preventing deaths through use of timely and effective medical care...
Date:
07/17/2008
, Publication:
NY TIMES
, Author:
REED ABELSON
http://www.nytimes.com/2008/07/17/business/17health.html?ref=health
FDA Revises Process for Responding to Drug Applications
The U.S. Food and Drug Administration today announced that it is revising the way it communicates to drug companies when a marketing application cannot be approved as submitted.
Date:
07/09/2008
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01859.html
Possible lymphoma link to TNF-blockers sparks agency review
...including adalimumab (Humira, Abbott), etanercept (Enbrel, Amgen/Wyeth), infliximab (Remicade, Centocor), and certolizumab pegol (Cimzia, UCB Inc.)for data on all cases of cancer reported in children and young adults...
Date:
06/06/2008
, Publication:
Drug Topics Daily News
, Author:
Heidi Belden, Pharm.D.
http://drugtopics.modernmedicine.com/drugtopics/Allergies/Possible-lymphoma-lin
F.D.A. Reviews Arthritis Drugs for Links to Cancer
...investigating whether four drugs used to treat rheumatoid arthritis and other immune system diseases might increase the risk of cancer in children.
Date:
06/05/2008
, Publication:
NY TIMES
, Author:
ANDREW POLLACK
http://www.nytimes.com/2008/06/05/business/05drug.html?ref=health
Group Urges Ban on Medical Giveaways
Drug and medical device companies should be banned from offering free food, gifts, travel and ghost-writing services to doctors,...
Date:
04/28/2008
, Publication:
NY TIMES
, Author:
GARDINER HARRIS
http://www.nytimes.com/2008/04/28/us/28doctors.html?ref=health
Before Medicare, Sticker Shock and Rejection
Less than a third of employers offer retiree health benefits, down from almost half in 1993, according to a survey
Date:
04/21/2008
, Publication:
NY TIMES
, Author:
FRED BROCK
http://www.nytimes.com/2008/04/21/business/retirement/21insure.html?_r=1&ref=he
Previous
Page 1 of 26
Next >
Search returned 259 items.
|
Sponsored Links
Reach these Drug Developers
Via Email or Mail List Rentals
www.biotechmedia.com
Medical Marketing & Media is a monthly
to 14,000 healthcare marketing executives
www.medicalmarketingandmedia.com
Smart strategic thinking and
innovative creative execution
www.adwise.com
|